Readout AI Secures Pre-Seed Funding to Decrease the Time from Clinical Trial Data to Clinical Trial Insight

LOS ANGELES, July 14, 2023 /PRNewswire/ -- Today, Readout AI is announcing it has raised its pre-seed funding. The round, led by Meridian Street Capital, with participation from Mucker Capital, Necessary Ventures, and angel investor Ryan Fukushima (COO of Tempus and CEO of Pathos), will...